Cathy Su

Cathy Su, PhD, has extensive experience in oncology and specialty therapeutics within the life sciences sector. Cathy served as a Consultant at Kantar Health from August 2019 to October 2021, managing custom strategy projects and leading the development of CancerMPact® reports. Prior roles include Engagement Manager at Oracle, where Cathy currently works, and multiple positions at IQVIA, including Associate Consultant and Consultant, focusing on global life science strategy for major pharmaceutical clients. Academic contributions include serving as a Graduate Teaching Assistant at Harvard University and conducting research at Harvard Medical School. Education includes a BA from Cornell University and a PhD from Harvard University.